Remdesivir doesn’t cure coronavirus. But the experimental drug, which may speed up recovery from a COVID-19 infection, is currently the best treatment we have against a virus that’s on a global rampage.
Late last week, the FDA authorized emergency use of the antiviral drug. The move came on the heels of preliminary results from a clinical trial that found patients treated with remdesivir had a 31 percent faster recovery than those who received a placebo. Average recovery was shortened to 11 days from 15 days, and the drug also slightly decreased the likelihood of dying from COVID-19.
